These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure. Babick AP; Dhalla NS Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941 [TBL] [Abstract][Full Text] [Related]
7. Cardiocirculatory dynamics in the normal and failing heart. Zelis R; Flaim SF; Liedtke AJ; Nellis SH Annu Rev Physiol; 1981; 43():455-76. PubMed ID: 6452090 [TBL] [Abstract][Full Text] [Related]
8. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485 [TBL] [Abstract][Full Text] [Related]
9. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure. Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957 [TBL] [Abstract][Full Text] [Related]
10. The myocardium in congestive heart failure. Katz AM Am J Cardiol; 1989 Jan; 63(2):12A-16A. PubMed ID: 2521266 [TBL] [Abstract][Full Text] [Related]
11. Direct Myosin Activation by Omecamtiv Mecarbil for Heart Failure with Reduced Ejection Fraction. Psotka MA; Teerlink JR Handb Exp Pharmacol; 2017; 243():465-490. PubMed ID: 28315072 [TBL] [Abstract][Full Text] [Related]
12. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943 [TBL] [Abstract][Full Text] [Related]
14. Heart spotting. el Azzouzi H; De Windt LJ Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799 [TBL] [Abstract][Full Text] [Related]
15. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769 [TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics. Warren JS; Oka SI; Zablocki D; Sadoshima J Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H584-H596. PubMed ID: 28646024 [TBL] [Abstract][Full Text] [Related]
17. Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure. Shen YT; Malik FI; Zhao X; Depre C; Dhar SK; Abarzúa P; Morgans DJ; Vatner SF Circ Heart Fail; 2010 Jul; 3(4):522-7. PubMed ID: 20498236 [TBL] [Abstract][Full Text] [Related]
18. Myocardial metabolic changes in cardiac hypertrophy and heart failure. Fizelova A; Fizel A Recent Adv Stud Cardiac Struct Metab; 1972; 1():200-12. PubMed ID: 4283436 [No Abstract] [Full Text] [Related]
19. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction. Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656 [TBL] [Abstract][Full Text] [Related]
20. Metabolic remodelling of the failing heart: beneficial or detrimental? van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]